Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.54 |
| ▸ | ACHE | P22303 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | TACR2 | P21452 | 3/20 | 0.42 |
| ▸ | NT5E | P21589 | 1/20 | 0.42 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.40 |
| ▸ | MTOR | P42345 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.40 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.40 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.40 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.40 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.40 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.40 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.40 |
| ▸ | FASN | P49327 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7525585 | 1.00 | BCHE (0.54) | BCHEACHELMNAHTR1ATACR2 | |
| SCHEMBL14571363 | 1.00 | BCHE (0.54) | BCHEACHELMNAHTR1ATACR2 | |
| SCHEMBL13591463 | 1.00 | BCHE (0.54) | BCHEACHELMNAHTR1ATACR2 | |
| SCHEMBL30801101 | 1.00 | BCHE (0.54) | BCHEACHELMNAHTR1ATACR2 | |
| SCHEMBL18497676 | 1.00 | BCHE (0.54) | BCHEACHELMNAHTR1ATACR2 | |
| SCHEMBL18852561 | 1.00 | BCHE (0.54) | BCHEACHELMNAHTR1ATACR2 | |
| SCHEMBL7522263 | 1.00 | BCHE (0.54) | BCHEACHELMNAHTR1ATACR2 | |
| SCHEMBL12896359 | 1.00 | BCHE (0.54) | BCHEACHELMNAHTR1ATACR2 | |
| SCHEMBL22796970 | 1.00 | BCHE (0.54) | BCHEACHELMNAHTR1ATACR2 | |
| SCHEMBL1087871 | 0.96 | BCHE (0.56) | BCHEACHELMNAHTR1ATACR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023126968-A1 | A PROCESS FOR THE SYNTHESIS OF BCX-1777 AND BCX-4430 | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2023-07-06 | — | — | WO | claimed |
| US-11612614-B2 | Isomorphs of Remdesivir and methods for synthesis of same | Anzalp Pharmasolutions Pvt. Ltd. (IN) | 2023-03-28 | — | — | US | claimed |
| US-20210228605-A1 | ISOMORPHS OF REMDESIVIR AND METHODS FOR SYNTHESIS OF SAME | Anzalp Pharmasolutions Pvt. Ltd. (IN) | 2021-07-29 | — | — | US | claimed |
| US-20210161927-A1 | ISOMORPHS OF REMDESIVIR AND METHODS FOR SYNTHESIS OF SAME | Anzalp Pharmasolutions Pvt. Ltd. (IN) | 2021-06-03 | — | — | US | claimed |
| US-20260000698-A1 | SARS-COV-2 NSP14 METHYLTRANSFERASE INHIBITORS | UNIV MINNESOTA (US) | 2026-01-01 | — | — | US | disclosed |
| EP-4591935-A2 | METHODS FOR THE PREPARATION OF RIBOSIDES | Gilead Sciences, Inc. (US) | 2025-07-30 | — | — | EP | disclosed |
| US-20250236623-A1 | PYRROLO[1,2-f][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS | GILEAD SCIENCES, INC. | 2025-07-24 | — | — | US | disclosed |
| EP-4588928-A2 | METHODS FOR TREATING FILOVIRIDAE VIRUS INFECTIONS | Gilead Sciences, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| EP-4323362-B1 | METHODS OF PREPARING CARBANUCLEOSIDES USING AMIDES | GILEAD SCIENCES INC (US) | 2025-05-07 | — | — | EP | disclosed |
| CN-113549120-B | Method for preparing ribonucleoside | 吉利德科学公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-108348526-B | Methods of treating arenaviridae and coronaviridae viral infections | 吉利德科学公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-113493480-B | Preparation and analysis method of Ruidexivir isomer | 南京正大天晴制药有限公司 | 2025-04-15 | — | — | CN | disclosed |
| WO-2010093608-A1 | CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | GILEAD SCIENCES, INC. (US) | 2010-08-19 | — | — | WO | disclosed |
| US-20100203015-A1 | CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | GILEAD SCIENCES, INC. (US) | 2010-08-12 | — | — | US | disclosed |
| US-20100203015-A1 | CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | GILEAD SCIENCES, INC. (US) | 2010-08-12 | — | — | US | disclosed |
| US-20100093991-A1 | METHODS FOR THE PREPARATION OF 9-DEAZAPURINE DERIVATIVES | BIO CRYST PHARMACEUTICALS , INC. (US) | 2010-04-15 | — | — | US | disclosed |
| US-20100021425-A1 | 1'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | GILEAD SCIENCES, INC. (US) | 2010-01-28 | — | — | US | disclosed |
| US-20100021425-A1 | 1'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | GILEAD SCIENCES, INC. (US) | 2010-01-28 | — | — | US | disclosed |
| WO-2009132135-A1 | 1' -SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | GILEAD SCIENCES, INC. (US) | 2009-10-29 | — | — | WO | disclosed |
| WO-1997041140-A1 | MODIFIED OLIGONUCLEOTIDES | NOVARTIS AG (CH) | 1997-11-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250236623-A1 | PYRROLO[1,2-f][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS | SYNJ1, SARS1, SYNJ2 | BCHE 4586/4885ACHE 4791/4885LMNA 2638/4885 |
| US-20100203015-A1 | CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | PNP, TYMP, MTAP | BCHE 3017/4885ACHE 4145/4885LMNA 1447/4885 |
| US-11612614-B2 | Isomorphs of Remdesivir and methods for synthesis of same | MTAP, SARS1, PNP | BCHE 641/4885ACHE 775/4885LMNA 3614/4885 |
| US-20100093991-A1 | METHODS FOR THE PREPARATION OF 9-DEAZAPURINE DERIVATIVES | DPYD, TYMP, UNG | BCHE 1635/4885ACHE 4464/4885LMNA 970/4885 |
| US-20100021425-A1 | 1'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | PNP, MTAP, SLC29A1 | BCHE 3342/4885ACHE 4231/4885LMNA 3262/4885 |
| US-20210228605-A1 | ISOMORPHS OF REMDESIVIR AND METHODS FOR SYNTHESIS OF SAME | MTAP, SARS1, PNP | BCHE 649/4885ACHE 799/4885LMNA 3567/4885 |
| US-20210161927-A1 | ISOMORPHS OF REMDESIVIR AND METHODS FOR SYNTHESIS OF SAME | MTAP, SARS1, PNP | BCHE 641/4885ACHE 775/4885LMNA 3614/4885 |
| US-20260000698-A1 | SARS-COV-2 NSP14 METHYLTRANSFERASE INHIBITORS | NSUN2, SARS1, RNMT | BCHE 1688/4885ACHE 2184/4885LMNA 1208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.